Conditions: Resectable Hepatocellular Carcinoma
Interventions: Drug: ateganosine; Drug: Cadonilimab
Sponsors: University of Texas Southwestern Medical Center; Maia Biotechnology; National Cancer Institute (NCI)
Not yet recruiting Conditions: Resectable Hepatocellular Carcinoma
Interventions: Drug: ateganosine; Drug: Cadonilimab
Sponsors: University of Texas Southwestern Medical Center; Maia Biotechnology; National Cancer Institute (NCI)
Not yet recruiting
